Nykredit's early stake in Dr. Reddy’s highlights investor confidence ahead of supply disruptions

Danish asset manager Nykredit disclosed a modest stake in Dr. Reddy’s Laboratories just before the Indian drugmaker faced setbacks due to a semaglutide supply issue, raising questions about investor foresight amidst operational turmoil. A Danish asset manager, Nykredit A/S, disclosed…















